Company / Capital Returned to Shareholders per Share
Tonix Pharmaceuticals Holding Corp. Capital Returned to Shareholders per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$3.14
FY2025
5-year range
$1.13 / $667.35
FY2023-FY2025
Trend
-99.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $1.13 to $3.14 over the past 2 years.
Based on SEC 10-K filings.
3.14 in FY2025.
Improved from $1.13 to $3.14 over the past 2 years.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, capital returned to shareholders per share decreased 99.5% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.14 | -99.5% |
| FY2024 | $667.35 | +59006.5% |
| FY2023 | $1.13 | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 28, 2026